TNFRSF11A and pulmonary fibrosis: Disruption of the RANKL/RANK axis with a mAb attenuated osteoclastogenesis and the histological, immunohistochemical, genetic, biochemical, and physiological hallmarks pulmonary fibrosis, suggesting RANKL as a promising target for future disease intervention.